Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:LacCer 18:1;O2/26:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003090 AN005054 Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B Cultured cells Mouse Rutgers University LC-MS
ST002843 AN004653 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) Liver Mouse Cancer Rutgers University LC-MS
ST002842 AN004651 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) Liver Mouse Cancer Rutgers University LC-MS
ST001877 AN003080 Targeted Sphingolipid analysis of HeLa knockout for expression of GRASP55 HeLa cells Human IBBC, CNR LC-MS
ST001673 AN002731 Targeted Sphingolipid analysis of HeLa silenced for or overexpressing GOLPH3 or LCS HeLa cells Human École polytechnique fédérale de Lausanne (EPFL) LC-MS
ST001672 AN002730 Targeted Sphingolipid analysis of human Fibroblasts silenced for or overexpressing GOLPH3 Fibroblast cells Human École polytechnique fédérale de Lausanne (EPFL) LC-MS
ST000004 AN000006 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS LC-MS
  logo